Clinical trial Recruiting at 1 site Interventional Ages 18 to 50

Face transplant with donor tissue and bone marrow stem cell infusion

Official title: Composite Tissue Allotransplantation of the Face: Anatomical and Functional Evaluation

Run by Centre Hospitalier Universitaire, Amiens · NCT02818400 · Data updated 2026-11-12

This will try face transplantation using donor facial tissue plus a bone marrow stem cell infusion for people with severe facial tissue loss that cannot be repaired with conventional surgery.

Quick facts

Study typeInterventional
Ages18 Years to 50 Years
SexAll
Enrollment5 (estimated)
SponsorCentre Hospitalier Universitaire, Amiens
Academic / other
Locations1 site (Amiens)
StatusRecruiting
StartedNovember 2009
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedMay 13, 2026
Trial IDNCT02818400 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with severe, unrepairable facial tissue loss who are medically and psychiatrically stable and meet the study's cardiac and renal function criteria would be considered candidates.

Probably not a fit

Patients whose facial defects can be managed with standard reconstructive surgery, or those with active or recent malignancy, severe psychiatric illness, poor cardiac or renal function, or uncontrolled hypertension are unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective series plans to enroll five patients over three years to test composite facial allotransplantation combined with bone marrow stem cell infusion to create microchimerism. Patients will receive standard immunosuppression alongside the donor facial graft and a planned stem cell infusion intended to improve mucocutaneous tolerance. Outcomes will include surgical feasibility, functional and aesthetic results, and safety monitored through clinical follow-up, imaging, and biopsy as needed. The protocol excludes patients whose defects are repairable by conventional reconstruction or who have significant medical or psychiatric contraindications.

Why it matters

Potential benefit: If successful, this approach could restore facial form and function in people with injuries that cannot be fixed by conventional reconstructive techniques.

How similar studies have gone: Several international teams have performed face transplants with reported functional and aesthetic gains, but the routine use of bone marrow stem cell infusion to induce microchimerism is less well established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with loss of unrepairable substance by conventional techniques shreds, at the front

Exclusion Criteria:

* Facial lesions repaired by conventional reconstructive surgery techniques
* History of malignancy in remission for less than 5 years
* Malignant neoplasm undergoing changes
* Severe psychiatric history
* Patients above a score of 2 on the scale of the ASA (American Society of Anesthesiology)
* Patients above a grade 1 in the classification NYHA ( New York Heart Association )
* insufficient with renal creatinine clearance less than 70 mL / min or presence of a proteinuria
* Severe hypertension

Where it's running

  • CHU Amiens
    Amiens, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.